| Authors: |
Bjelosevic S; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Fauth R; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Do BT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Harvard-MIT Health Sciences and Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Merickel LA; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Jackson TD; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA., Basanthakumar AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Taillon A; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Salhotra S; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Ryback B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA., Schneider C; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., DiGiovanni G; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Elbashir R; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA., Burger N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA., Bin Munim M; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA., Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Puigserver P; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA.; Department of Cell Biology, Harvard Medical School, Boston, MA, 02215 USA., Root DE; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA., Vander Heiden MG; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02142 USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215 USA., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, MA, 02215 USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142 USA.; Lead contact. |
